Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pneumology : what's new in 2025].

Revue medicale suisseยท2026
Same author

Impact of the establishment of a multidisciplinary national chronic thromboembolic pulmonary hypertension board on a monocentric surgical endarterectomy program.

Interdisciplinary cardiovascular and thoracic surgeryยท2025
Same author

Acute fibrinous and organizing pneumonia after lung transplantation: A case report of treatment with infliximab and tocilizumab and literature review.

Respiratory medicine case reportsยท2025
Same author

Harnessing deep learning to detect bronchiolitis obliterans syndrome from chest CT.

Communications medicineยท2025
Same author

[Pneumology : what's new in 2024].

Revue medicale suisseยท2025
Same author

Acute Stent Recoil After Left Main Coronary Artery PCI for Extrinsic Compression by Pulmonary Trunk.

Journal of the Society for Cardiovascular Angiography & Interventionsยท2024

Related Experiment Video

Updated: Jun 26, 2026

Orthotopic Left Lung Transplantation in Rats
08:22

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Lung transplantation for COPD - evidence-based?

Samir Lahzami1, John-David Aubert

  • 1Service de pneumilogie, CHUV, Lausanne, Switzerland.

Swiss Medical Weekly
|January 15, 2009
PubMed
Summary
This summary is machine-generated.

Lung transplantation offers COPD patients improved lung function and quality of life. Evidence suggests it may also improve survival when appropriate patient selection criteria are used.

More Related Videos

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Related Experiment Videos

Last Updated: Jun 26, 2026

Orthotopic Left Lung Transplantation in Rats
08:22

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Area of Science:

  • Pulmonology
  • Transplant Surgery
  • Medical Research

Background:

  • Lung transplantation is a critical treatment for end-stage chronic obstructive pulmonary disease (COPD), representing over a third of global procedures.
  • COPD remains the primary indication for lung transplantation worldwide.
  • While beneficial for lung function, exercise capacity, and quality of life, the survival benefit of lung transplantation in COPD patients is challenging to definitively establish.

Purpose of the Study:

  • To evaluate the impact of lung transplantation on survival in patients with chronic obstructive pulmonary disease (COPD).
  • To review the evidence supporting the survival benefit of lung transplantation for COPD patients.

Main Methods:

  • Analysis of existing data and indirect evidence regarding lung transplantation outcomes in COPD patients.
  • Consideration of methodological challenges, including the lack of randomized controlled trials.

Main Results:

  • Lung transplantation in COPD patients demonstrates clear positive effects on lung function, exercise capacity, and quality of life.
  • Methodological difficulties, such as the absence of randomized studies, complicate the assessment of survival benefit.
  • Indirect but convincing evidence suggests a potential survival benefit for carefully selected COPD patients undergoing lung transplantation.

Conclusions:

  • Lung transplantation can significantly enhance the quality of life and post-transplant lifestyle for COPD patients.
  • Appropriate selection criteria are crucial for maximizing the benefits, including potential survival advantages, of lung transplantation in COPD.
  • Further research may be needed to definitively quantify the survival benefit due to inherent study design limitations.